SILVIA OLIVARES MENDOZA: Open Payments
NPI 1811661614 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,114 in 161 payments from 20 companies in 2025. Trend: 2023 $364 · 2024 $1,804 · 2025 $3,114
Food & beverage: $2,950Education: $164
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $567 |
| GlaxoSmithKline, LLC. | 27 | $421 |
| JAZZ PHARMACEUTICALS INC. | 7 | $299 |
| Insmed, Inc. | 14 | $255 |
| GENZYME CORPORATION | 7 | $187 |
| Regeneron Healthcare Solutions, Inc. | 11 | $181 |
| Viatris Specialty LLC | 13 | $166 |
| Verona Pharma, Inc. | 15 | $162 |
| Amgen Inc. | 9 | $135 |
| HARMONY BIOSCIENCES LLC | 6 | $124 |
Products named: DUPIXENT, XYWAV, Arikayce, TEZSPIRE, AIRSUPRA, NUCALA, TRELEGY ELLIPTA, FASENRA.
Industry payments across OK — which companies pay providers there.
